Growth of Medicare Advantage After Plan Payment Reductions.
Journal
JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500
Informations de publication
Date de publication:
02 Jun 2023
02 Jun 2023
Historique:
medline:
26
6
2023
pubmed:
24
6
2023
entrez:
24
6
2023
Statut:
epublish
Résumé
Various policy proposals would reduce federal payments to Medicare Advantage (MA) plans. However, it is unclear whether payment reductions would compromise beneficiary access to the MA program. To quantify the association between MA payment reductions under the Affordable Care Act (ACA) and MA enrollment growth. This retrospective cohort study examined the MA market before and after the ACA, which mandated cuts to MA benchmark payment rates. Using 2008 to 2019 county-level enrollment and payment data, a difference-in-differences analysis was conducted comparing MA enrollment changes between counties with larger vs smaller benchmark reductions, before vs after the ACA. The primary outcome was the MA enrollment rate, defined as the proportion of a county's Medicare beneficiaries enrolled in MA. A secondary analysis examined MA plan payments per member per month. Among 3138 counties with 37 639 county-year observations, ACA-induced benchmark cuts were sizeable and varied, ranging from 0% to 42.9% (mean [SD], 5.9% [6.6%]). Counties with benchmark cuts above the 75th percentile had population-weighted average benchmark cuts of 14.9% compared with 4.4% in other counties. In the 8 years following the ACA, there was no differential change in MA enrollment between counties with larger vs smaller benchmark cuts (difference-in-differences estimate, 0.02 [95% CI, -1.18 to 1.21] percentage points; P = .98). Plan payments differentially fell in counties with larger benchmark cuts by $78.35 (95% CI, $62.21-$94.48) per member per month (P < .001). This cohort study found no evidence that the MA benchmark and ensuing payment cuts imposed by the ACA were associated with reduced MA enrollment, compromising access to MA. This evidence can inform ongoing policy debates regarding the growth of MA, concerns about excess payments to MA plans, and proposed Medicare reforms, including further reductions in MA payments.
Identifiants
pubmed: 37354538
pii: 2806616
doi: 10.1001/jamahealthforum.2023.1744
pmc: PMC10290750
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e231744Références
Am Econ J Appl Econ. 2019 Apr;11(2):302-332
pubmed: 31131073
J Health Econ. 2013 Dec;32(6):1289-300
pubmed: 24308880
Health Serv Res. 2012 Dec;47(6):2339-52
pubmed: 22578065
JAMA Health Forum. 2021 Dec 10;2(12):e214001
pubmed: 35977297
Health Aff (Millwood). 2012 Dec;31(12):2609-17
pubmed: 23213144
Am Econ Rev. 2018 Aug;108(8):2048-87
pubmed: 30091862
JAMA Health Forum. 2022 Sep 2;3(9):e222935
pubmed: 36218933
JAMA. 2022 Dec 6;328(21):2126-2135
pubmed: 36472594
Health Aff (Millwood). 2021 Jun;40(6):937-944
pubmed: 34097516